Clinical Trials Browser

Withdrawn × NIH × Papillomavirus Infections × Clear all

NCT04044950 2020-09-22

A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal Cancer

Phase 2 Withdrawn

Oropharyngeal Neoplasms, Papillomavirus Infections